KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Invested Capital (2016 - 2025)

Boston Scientific (BSX) has disclosed Invested Capital for 17 consecutive years, with $24.8 billion as the latest value for Q4 2025.

  • Quarterly Invested Capital rose 12.78% to $24.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.8 billion through Dec 2025, up 12.78% year-over-year, with the annual reading at $24.8 billion for FY2025, 12.78% up from the prior year.
  • Invested Capital hit $24.8 billion in Q4 2025 for Boston Scientific, down from $35.0 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $35.0 billion in Q3 2025 to a low of $483.0 million in Q2 2025.
  • Historically, Invested Capital has averaged $16.6 billion across 5 years, with a median of $12.7 billion in 2024.
  • Biggest five-year swings in Invested Capital: surged 25163.89% in 2021 and later tumbled 96.48% in 2022.
  • Year by year, Invested Capital stood at $29.1 billion in 2021, then crashed by 96.48% to $1.0 billion in 2022, then skyrocketed by 2696.09% to $28.6 billion in 2023, then fell by 23.15% to $22.0 billion in 2024, then increased by 12.78% to $24.8 billion in 2025.
  • Business Quant data shows Invested Capital for BSX at $24.8 billion in Q4 2025, $35.0 billion in Q3 2025, and $483.0 million in Q2 2025.